US$ 22.75
glp-1 alzheimer's study Role of glucagon-like peptide-1 receptor agonists in disease and Parkinson's disease | Journal of Biomedical Science Details of failed studies cast
Description
doi:10.2337/diacare.25.8.1398 65

Its an argument for fighting for better insurance coverage and pricing, not for psychiatrists avoiding prescribing them

Virtas published outcomes include an average A1C reduction of 1.3% and significant reductions in diabetes medication use at one year

95% CI 0.61 0.98
But heres the interesting part: as LDL dropped, markers of cholesterol synthesis increased
